Skip to main content

GALZIN

Generic: Zinc Acetate

Verified·Sep 7, 2026
Manufacturer
Teva
NDC
71863-124
RxCUI
199994
Route
ORAL
ICD-10 indication
E75.22

Affordability Check

How much will you actually pay for GALZIN?

In 30 seconds, see every legitimate way to afford GALZIN — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About GALZIN

What is this medication?

Galzin is a prescription medication containing zinc acetate that is primarily used for the maintenance treatment of patients with Wilson's disease. Wilson's disease is an inherited condition that prevents the body from properly eliminating copper, leading to a dangerous buildup of the metal in the liver, brain, and other organs. This medication is generally intended for patients who have already undergone initial treatment with chelating agents to remove excess copper and now require long-term management to prevent the metal from accumulating again.

The medication functions by increasing the levels of a protein called metallothionein within the cells of the intestinal tract. This protein binds to copper from both the diet and digestive secretions, preventing the copper from being absorbed into the bloodstream. Once the copper is bound to the protein in the intestinal lining, it is eventually eliminated from the body through the stool as the intestinal cells are naturally shed. By effectively blocking copper absorption, Galzin helps maintain stable copper levels and protects the body from the toxic effects of copper overload.

Copay & patient assistance

  • Patient Copay Amount: $0
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Commercially eligible patients
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for GALZIN. Official source: DailyMed (NLM) · Label effective Dec 26, 2023

Indications and usage
For the temporary relief of pain and itching associated with rashes due to poison ivy, oak and sumac insect bites minor skin irritations minor cuts dries the oozing and weeping of poison ivy, oak, and sumac
Dosage and administration
Adults and children 2 years or older: apply to affected are not more than 3 to 4 times daily. Children under 2 years of age: ask a doctor. To apply to face, spray into palm of hand and gently apply.
Warnings
For external use only. Flammable. Keep away from fire or flame. Do not use on deep or puncture wounds, animal bites, or serious burns. When using this product avoid contact with eyes. In case of contact with eyes, flush thoroughly with water. avoid contact with broken skin, do not inhale or ingest, contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120F. Stop use and ask a doctor if condition worsens, rash or irritation develops and lasts for more than 7 days or clears up and occurs again within a few days.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

GALZIN treats a rare condition. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.